Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Better Therapeutics Inc (NQ: BTTX )

0.2316 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.2316
Bid (Size) 0.2254 (2)
Ask (Size) 0.2316 (1)
Prev. Close 0.2316
Today's Range 0.2316 - 0.2316
52wk Range 0.1367 - 1.610
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Diabetes Is The Most Expensive Chronic Condition In America With Healthcare Costs Continuing To Rise, Making Addressing Its Root Causes Even More Important
A study conducted by the CDC projects a potential 700% increase in the number of people under the age of 20 diagnosed with type 2 diabetes by2060. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga

Performance

YTD
-78.95%
-78.95%
1 Month
+53.38%
+53.38%
3 Month
-60.44%
-60.44%
6 Month
-76.36%
-76.36%
1 Year
-83.69%
-83.69%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Better Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics: Q3 Earnings Insights
Via Benzinga
Why Gap Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Frost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership Award
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023
From Better Therapeutics
Via Business Wire
Top 5 Health Care Stocks That Are Preparing To Pump In November
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Better Therapeutics to Participate in the American College of Lifestyle Medicine’s 2023 Annual Conference
From Better Therapeutics, Inc.
Via Business Wire
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Avidity Biosciences Shares Are Trading Higher By Around 9%: 20 Stocks Moving Premarket
Via Benzinga
Better Therapeutics Announces Publication of LivVita Liver Disease Study Results in Gastro Hep Advances
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
From Better Therapeutics, Inc.
Via Business Wire
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Better Therapeutics Announces New Data Highlighting Concurrent Use of AspyreRx and GLP-1 Receptor Agonists to Treat Type 2 Diabetes
From Better Therapeutics, Inc.
Via Business Wire
Why Glimpse Group Shares Are Trading Lower By Around 41%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Better Therapeutics Completes Enrollment in Real-World Evidence Program Evaluating Long-term Effectiveness of AspyreRx in Type 2 Diabetes
From Better Therapeutics, Inc.
Via Business Wire
Diabetes Prevalence Continues To Rise – Better Therapeutics' Digital Treatment Could Help Change This Trajectory
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.